Related Experiment Video
Updated: May 10, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
B-cell activating factor (BAFF) is elevated in chronic granulomatous disease
Kabir Matharu1, Kol A Zarember, Beatriz E Marciano
1Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Chronic Granulomatous Disease (CGD) involves increased B-cell activating factor (BAFF) due to inflammation. This study found elevated BAFF in CGD patients, linked to inflammatory markers and reduced B-cell receptor expression.
Area of Science:
- Immunology
- Genetics
- Inflammation Biology
Background:
- Chronic Granulomatous Disease (CGD) is an inherited immune disorder characterized by impaired superoxide production, leading to severe infections and granuloma formation.
- Abnormalities in immunoglobulin concentrations have been suggested in CGD, prompting investigation into factors controlling antibody production.
Purpose of the Study:
- To investigate alterations in B-cell activating factor (BAFF) levels and related molecules in patients with Chronic Granulomatous Disease.
- To determine the relationship between BAFF concentrations, inflammation markers, and B-cell receptor expression in CGD.
Main Methods:
- Plasma BAFF concentrations were measured in CGD subjects and healthy donors using quantitative assays.
- BAFF levels were compared between CGD patients with and without IFN-γ treatment.
- In vitro studies assessed BAFF production by CGD leukocytes stimulated with IFN-γ or G-CSF.
- Expression of BAFF receptors (BAFF-R, TACI) on B cells was analyzed.
- Correlations between BAFF, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), IgM, and BAFF response to endotoxin were examined.
Main Results:
- CGD subjects exhibited significantly higher plasma BAFF concentrations (2.3-fold increase) compared to healthy donors (p < 0.0001).
- Patients receiving IFN-γ treatment showed higher BAFF levels than those not on treatment (1.6-fold increase, p < 0.005).
- CGD leukocytes produced normal BAFF levels in vitro upon stimulation.
- B cells from CGD subjects displayed significantly reduced expression of BAFF-R and TACI.
- Elevated BAFF correlated with inflammatory markers (CRP, ESR) and IgM levels in CGD patients.
Conclusions:
- Elevated BAFF in CGD is associated with chronic inflammation and potentially linked to altered B-cell receptor expression.
- These findings suggest that increased BAFF in CGD and healthy individuals may be a response to acute and chronic inflammatory processes.
- BAFF may play a role in the immune dysregulation observed in Chronic Granulomatous Disease.
Related Concept Videos
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Inflammation: Introduction

